GPRC5D-Targeted CAR T Cells for Myeloma.
N Engl J Med. 2022 Sep 29;387(13):1196-1206. doi: 10.1056/NEJMoa2209900.
N Engl J Med. 2022.
PMID: 36170501
Clinical Trial.